(Q46367793)

21 December 2017

title

Disruption of the blood-brain barrier by intra-arterial administration of papaverine: a technical note (English)

1 reference

21 December 2017

1 reference

Johannes Platz

1

1 reference

21 December 2017

Krisztina Baráth

series ordinal

2

1 reference

21 December 2017

Emanuela Keller

series ordinal

3

1 reference

21 December 2017

Anton Valavanis

series ordinal

4

1 reference

21 December 2017

language of work or name

1 reference

13 September 2008

1 reference

21 December 2017

published in

Neuroradiology

1 reference

21 December 2017

volume

50

1 reference

21 December 2017

issue

12

1 reference

21 December 2017

page(s)

1035-1039

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1007/s00234-008-0455-x

exact match

0 references

cites work

Intracranial pressure changes induced during papaverine infusion for treatment of vasospasm

1 reference

12 December 2020

Multimodal quantitation of the effects of endovascular therapy for vasospasm on cerebral blood flow, transcranial doppler ultrasonographic velocities, and cerebral artery diameters

1 reference

12 December 2020

Combined endovascular treatment for both intracranial aneurysm and symptomatic vasospasm

1 reference

12 December 2020

Intraarterial infusion of high-concentration papaverine damages cerebral arteries in rats.

1 reference

12 December 2020

Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm

1 reference

12 December 2020

Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhage-associated vasospasm: initial clinical experience with high-dose infusions.

1 reference

12 December 2020

Indications for endovascular therapy for refractory vasospasm after aneurysmal subarachnoid hemorrhage: experience at the University of Cincinnati

1 reference

12 December 2020

MMP-9 and EBA immunoreactivity after papaverine mediated opening of the blood-brain barrier.

1 reference

12 December 2020

Endovascular treatment of cerebral vasospasm

1 reference

12 December 2020

Effect of intra-arterial papaverine on regional cerebral blood flow in hemodynamically relevant cerebral vasospasm

1 reference

12 December 2020

CT angiography and perfusion CT in cerebral vasospasm after subarachnoid hemorrhage.

1 reference

12 December 2020

Utility of computed tomography perfusion in detection of cerebral vasospasm in patients with subarachnoid hemorrhage

1 reference

12 December 2020

Cerebral perfusion imaging in vasospasm

1 reference

12 December 2020

Mechanisms of action of transmitters and other substances on smooth muscle

1 reference

12 December 2020

Vasospasm after subarachnoid hemorrhage: utility of perfusion CT and CT angiography on diagnosis and management.

1 reference

12 December 2020

Estimation of cerebral oxygenation and hemodynamics in cerebral vasospasm using indocyaningreen dye dilution and near infrared spectroscopy: a case report

1 reference

12 December 2020

Intra-arterial papaverine treatment for cerebral vasospasm: our experience and review of the literature

1 reference

12 December 2020

In vitro evaluation of papaverine hydrochloride incompatibilities: a simulation of intraarterial infusion for cerebral vasospasm

1 reference

12 December 2020

Improvement of cerebral oxygenation patterns and metabolic validation of superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm.

1 reference

12 December 2020

Intraarterial infusion of papaverine and change of cerebral hemodynamics in symptomatic cerebral vasospasm

1 reference

12 December 2020

High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Endovascular treatment strategies for cerebral vasospasm

1 reference

12 December 2020

Update on endovascular therapies for cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Treatment of cerebral vasospasm with intra-arterial papaverine

1 reference

12 December 2020

Endovascular treatment of cerebral vasospasm: assessment of treatment effect by cerebral angiography and transcranial colour Doppler sonography.

1 reference

12 December 2020

Paradoxical aggravation of vasospasm with papaverine infusion following aneurysmal subarachnoid hemorrhage. Case report

1 reference

12 December 2020

Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration

1 reference

12 December 2020

Effectiveness of intra-arterially infused papaverine solutions of various concentrations for the treatment of cerebral vasospasm

1 reference

12 December 2020

Effect of intraarterial papaverine and/or angioplasty on the cerebral veins in patients with vasospasm after subarachnoid hemorrhage due to ruptured intracranial aneurysms

1 reference

12 December 2020

Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion

1 reference

12 December 2020

Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage

1 reference

12 December 2020

Intra-arterial papaverine for the treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

1 reference

12 December 2020

Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm.

1 reference

12 December 2020

Clinical, angiographic, and sonographic findings after structured treatment of cerebral vasospasm and their relation to final outcomes

1 reference

12 December 2020

Cerebral vasospasm: results of a structured multimodal treatment

1 reference

12 December 2020

Intra-arterial papaverine-induced seizures: case report and review of the literature

1 reference

12 December 2020

10.1007/S00234-008-0455-X

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

18791708

1 reference

21 December 2017